MyLeukemiaTeam

What is the prognosis for chronic myelomonocytic leukemia (CMML)?

The prognosis for CMML varies based on several factors, but overall survival rates differ significantly by subtype:

Survival Rates by CMML Type
- Type 0 or 1 CMML: About 20 percent of people live for five years or more after diagnosis
- Type 2 CMML: About 10 Show Full Answer

What is the prognosis for chronic myelomonocytic leukemia (CMML)?

The prognosis for CMML varies based on several factors, but overall survival rates differ significantly by subtype:

Survival Rates by CMML Type:
- Type 0 or 1 CMML: About 20 percent of people live for five years or more after diagnosis
- Type 2 CMML: About 10 percent of people live for five years or more after diagnosis

Risk of Progression:
About 15 percent to 30 percent of people with CMML later develop acute myeloid leukemia (AML). The rate varies by subtype:
- Type 0 or 1 CMML: About 18 percent develop AML within five years
- Type 2 CMML: About 63 percent develop AML within five years

Factors That Influence Your Prognosis:
- Your age
- Whether you have other health conditions
- Your blood cell counts
- Which genetic changes your CMML cells have
- Your levels of lactate dehydrogenase (LDH)
- Your CMML subtype

Your healthcare team can help you understand how your individual characteristics affect your specific outlook with CMML.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Chronic Myelomonocytic Leukemia: An Overview